Edgestream Partners »

Ptc Therapeutics I shares owned by Edgestream Partners

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $988k 36k 27.56

More positions owned by Edgestream Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Reliance Steel & Aluminum (RS)
EastGroup Properties (EGP)
Watts Water Technologies Cl A (WTS)
Targa Res Corp (TRGP)
Amedisys (AMED)
Rithm Capital Corp Com New (RITM)

View all positions for Edgestream Partners

Top funds holding Ptc Therapeutics I

Wellington Management Company
Vanguard Group
Cowen And Company
Henderson Group
Franklin Resources
D. E. Shaw & Co
Jacobs Levy Equity Management
Blackstone Group
T. Rowe Price Associates
Tang Capital Management
Voloridge Investment Management
Jane Street
Jpmorgan Chase & Co
Charles Schwab Investment Management
Norges Bank Investment Management

View all funds holding Ptc Therapeutics I